AU2002241670A1 - Method for treating glaucoma IB - Google Patents

Method for treating glaucoma IB

Info

Publication number
AU2002241670A1
AU2002241670A1 AU2002241670A AU2002241670A AU2002241670A1 AU 2002241670 A1 AU2002241670 A1 AU 2002241670A1 AU 2002241670 A AU2002241670 A AU 2002241670A AU 2002241670 A AU2002241670 A AU 2002241670A AU 2002241670 A1 AU2002241670 A1 AU 2002241670A1
Authority
AU
Australia
Prior art keywords
treating glaucoma
glaucoma
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002241670A
Other versions
AU2002241670B2 (en
Inventor
Stanley C. Bell
John J. Egan
Martin Gall
Edmond J. Lavoie
Sara Vasan
Dilip Wagle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synvista Therapeutics Inc
Original Assignee
Alteon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alteon Inc filed Critical Alteon Inc
Priority claimed from PCT/US2001/049550 external-priority patent/WO2002053158A1/en
Publication of AU2002241670A1 publication Critical patent/AU2002241670A1/en
Application granted granted Critical
Publication of AU2002241670B2 publication Critical patent/AU2002241670B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002241670A 2000-12-29 2001-12-28 Method for treating glaucoma IB Ceased AU2002241670B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US25942600P 2000-12-29 2000-12-29
US60/259,426 2000-12-29
US29625701P 2001-06-06 2001-06-06
US60/296,257 2001-06-06
US30741801P 2001-07-24 2001-07-24
US60/307,418 2001-07-24
PCT/US2001/049550 WO2002053158A1 (en) 2000-12-29 2001-12-28 Method for treating glaucoma ib

Publications (2)

Publication Number Publication Date
AU2002241670A1 true AU2002241670A1 (en) 2003-01-23
AU2002241670B2 AU2002241670B2 (en) 2006-08-17

Family

ID=27401231

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002241670A Ceased AU2002241670B2 (en) 2000-12-29 2001-12-28 Method for treating glaucoma IB

Country Status (9)

Country Link
US (1) US7432254B2 (en)
EP (1) EP1353669B1 (en)
JP (1) JP2004520329A (en)
AT (1) ATE369856T1 (en)
AU (1) AU2002241670B2 (en)
CA (1) CA2433346A1 (en)
DE (1) DE60130030T2 (en)
MX (1) MXPA03005922A (en)
WO (1) WO2002053158A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062250A1 (en) * 2000-02-23 2001-08-30 Alteon, Inc. Thiazolium compounds and treatments of disorders associated with protein aging
ES2251500T3 (en) * 2000-07-13 2006-05-01 Alteon, Inc. TIAZOLS AND IMIDAZOLS REPLACED BY CYANOMETILE AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING.
US7049333B2 (en) 2002-06-04 2006-05-23 Sanofi-Aventis Deutschland Gmbh Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
CN100349881C (en) * 2003-04-02 2007-11-21 深圳市东阳光实业发展有限公司 New substituted penta azacyclo salt kind compound and its use in treating protein ageing related disease
US20050014747A1 (en) * 2003-04-18 2005-01-20 Emily Reinhard Dihydrothiazine prodrugs of thiazolium agents
JP4791361B2 (en) 2003-08-26 2011-10-12 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル） Ionic liquids based on imidazolium salts incorporating nitrile functional groups
EP1732905A1 (en) 2004-03-31 2006-12-20 Lexicon Genetics Incorporated 2-aminomethylthiazole-5-carboxamides as protein kinase modulators
JP2008506714A (en) 2004-07-16 2008-03-06 サネシス ファーマシューティカルズ， インコーポレイテッド Thienopyrimidines useful as aurora kinase inhibitors
US8921406B2 (en) 2005-08-21 2014-12-30 AbbVie Deutschland GmbH & Co. KG 5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
IL223022A0 (en) 2010-05-14 2013-02-03 Texas A & M Univ Sys Functional, cross-linked nanostructures for tandem optical imaging and therapy

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ200429A (en) * 1981-04-30 1984-10-19 Smith & Nephew Ass Applicator for placing pharmaceutically active agent in contact with moist surface,e.g.,eye
US5140048A (en) * 1984-03-19 1992-08-18 The Rockefeller University Inhibitors of nonenzymatic cross-linking
US5017696A (en) * 1987-09-17 1991-05-21 The Rockefeller University Advanced glycosylation end products and associated methods
ATE117208T1 (en) * 1990-05-22 1995-02-15 R Tech Ueno Ltd TREATMENT OF INTRAOCULAR PRESSURE WITH AN OPHTHALMIC SYNERGISTIC COMBINATION.
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
US5153205A (en) * 1990-10-01 1992-10-06 Merck & Co., Inc. Method to reduce introacular pressure without causing miosis
US5300031A (en) * 1991-06-07 1994-04-05 Liebel-Flarsheim Company Apparatus for injecting fluid into animals and disposable front loadable syringe therefor
NO315930B1 (en) 1995-01-18 2003-11-17 Picower Inst For Medical Res T Use of Thiazolium Compounds in the Preparation of Pharmaceutical Preparations, Compounds Containing the Compounds, and Nyetiazolium Compounds
US5656261A (en) * 1995-01-18 1997-08-12 The Picower Institute For Medical Research Preventing and reversing advanced glycosylation endproducts
EP0808163B1 (en) * 1995-01-18 2003-07-23 Alteon, Inc. Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
US5744451A (en) * 1995-09-12 1998-04-28 Warner-Lambert Company N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
US5854000A (en) * 1995-11-15 1998-12-29 Alteon Inc. Methods for measurement predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
US6121300A (en) * 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
CA2448294A1 (en) * 2001-05-30 2002-12-05 Alteon Inc. Method for treating fibrotic diseases or other indications vi
WO2002096317A2 (en) * 2001-05-30 2002-12-05 Alteon, Inc. Method for treating glaucoma vi
JP2004536807A (en) * 2001-05-30 2004-12-09 アルテオン インコーポレイテッド How to treat glaucoma V

Similar Documents

Publication Publication Date Title
WO2002030487A8 (en) Methods for treating aneurysms
AU2001245522A1 (en) Apparatus and method for treating glaucoma
EP1414464A4 (en) Method for treating glaucoma v
AU2002215125A1 (en) Well treatment method
AU2001231104A1 (en) Methods for treating diabetes
AU2001219185A1 (en) 2-acylaminobenzimidazole derivatives for treating glaucoma
AU2651701A (en) Method for introducing additives
AU2001269799A1 (en) Methods for treating various eye disorders
AU2016701A (en) Secure communications method
AU2001237939A1 (en) Methods for treating glaucoma
AU2042301A (en) 1-aminoalkyl-1H-indoles for treating glaucoma
AU2002225930A1 (en) Methods for treating phosphatide-containing mixtures
AUPR617901A0 (en) Method for treating multiple myeloma
AUPR152100A0 (en) Method for treating coral
AU2002241670A1 (en) Method for treating glaucoma IB
AU2001277938A1 (en) Method for treating angina
EP1358225B8 (en) Method for treating emulsion polymers
AU2002214487A1 (en) Method for inducing apoptiosis
AU1603401A (en) Pyranoindoles for treating glaucoma
AU2001237530A1 (en) Method
AU2002326991A1 (en) Methods for treating multiple sclerosis
AU2001241636A1 (en) Halotherapy method
EP1359910A4 (en) Method for treating glaucoma ii b
AU2001243297A1 (en) Method for treating or preventing depression
AU2002241687A1 (en) Method for treating glaucoma ii b